GenomeScan is a core biosafety testing facility for multiple pharmaceutical and biotechnology companies specializing in antibody, vaccine and gene therapy manufacturing. We offer a wide range of solutions that meet our clients' specific needs, including genetic characterization, microbial identification, viral safety testing, and mycoplasma detection. Our assays are designed to be fast, accurate, and cost-effective, helping our partners to save time and resources in the development and commercialization of their products.

Our 20+ years of experience in the industry and strong, in-house expertise in NGS coupled with robust bioinformatics pipelines let us stand out with the quality of our services. Additionally, short turnaround times and workflows that adhere to ISO/IEC 17025, ISO15189 and GMP guidelines help you advance to the next stage of your development and production programs with confidence. To learn more about GenomeScan, visit www.genomescan.nl.